RZ-402

N/A

Report date: 2022/12/19 13:39:22
NME

Base Information

Drug NameRZ-402
Drug Alias NameRZ-402AB-402ASP-440
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKallikreins inhibitors
TargetsKallikreins
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRezolute
China Registration ClassN/A

Develop Information

Active CompaniesRezolute
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A